You are here

    • You are here:
    • Home > EVENTS > CRG Scientific Sessions

CRG Scientific Sessions

CRG Scientific Sessions

24/10/201912:00R_473.10_AULAPRBB Computational Genomics SeminarsAngela Leis MachínLaura Furlong's lab (UPF) / Sergi Beltran's lab (CNAG)Detecting Signs of Depression in Tweets in Spanish: Behavioral and Linguistic AnalysisHost: Garrido Enamorado, Romina

06/11/201915:00RAMÓN Y CAJALGene Regulation,Stem Cells&Cancer Progr.Alessandra MagistratoNational Research Council (CNR)-IOM and International School for Advanced Studies, Trieste. Italy"Atomic-level simulations of splicing: from the catalytic mechanism to its functional modulation by the protein environment"Host: Valcárcel Juárez, Juan

08/11/201912:00MARIE CURIEPRBB-CRG SessionsCarl-Phillip HeinsenbergIST Austria"to be determined"Host: Verena Ruprecht (CRG)

11/11/201912:00MARIE CURIEPRBB-CRG SessionsMike FeoloNational Center for Biotechnology Information, US"dbGaP: Data and Data processing"Host: Jordi Rambla (CRG)Abstract:The National Center for Biotechnology Information (NCBI) database of Genotypes and Phenotypes (dbGaP) provides unprecedented access to very large genetic and phenotypic datasets funded by the U.S. National Institutes of Health, and other funding agencies worldwide. Through controlled access, approved researchers from across the globe may obtain access to complete statistical analyses, individual phenotype information and molecular data. This presentation will summarize the data content, technical and biological...

18/11/201912:00MARIE CURIEPRBB-CRG SessionsNaama BarkaiWeizmann Institute of Science, IL"to be determined"Host: Postdoc students

22/11/201912:00MARIE CURIEPRBB-CRG SessionsPhilippe SanseauHead Computational Biology, GSK, UK"Use of highly-dimensional genetics and genomics data for drug discovery"Host: Roderic Guigó (CRG)Abstract:Drug discovery and development remains a very long and costly process. The majority of projects will fail due to lack of efficacy or because of safety concerns. This could happen at multiple stages but the later it is, the more expensive is the failure. Therefore, the choice of drug targets is very important since the outcome might not be known for many years. We have shown that using human genetics information may increase the chance of success in the clinic for new drug targets. In addition, the new functional genomics technologies...

25/11/201912:00MARIE CURIEPRBB-CRG SessionsAshby J. MorrisonDepartment of Biology, Stanford Biology, US"Epigenetic Regulation of Carcinogen Susceptibility"Host: Ben Lehner (CRG)Abstract:The development of many sporadic cancers is directly initiated by carcinogen exposure. Despite this knowledge, there has been remarkably little investigation into the factors that regulate susceptibility to acquire carcinogen-induced DNA lesions. Our research identifies the epigenetic regulators of carcinogen susceptibility and establish it as an origin of genome instability that mirrors mutagenesis in cancer.

27/11/201915:00RAMÓN Y CAJALGene Regulation,Stem Cells&Cancer Progr.Jennifer MitchellAssociate Professor, Department of Cell and Systems Biology, University of Toronto. Canada"Using CRISPR genome editing and comparative epigenomics to determine the transcriptional regulatory code for pluripotent stem cells"Host: Cosma, Maria Pia

29/11/201912:00MARIE CURIEPRBB-CRG SessionsInbal GoshenThe Edmond & Lily Safra, Centre for Brain Sciences, The Hebrew University of Jerusalemto be determinedHost: Mara Dierssen (CRG)

13/12/201912:00MARIE CURIEPRBB-CRG SessionsJitu MayorNational Centre for Biological Sciences, Bangalore, India"to be determined"Host: Vivek Malhotra (CRG)

16/12/201912:00MARIE CURIEPRBB-CRG SessionsCédric BlanpainWELBIO, Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles, BE"to be determined"Host: Antoni Celià Terrassa (IMIM)

17/01/202012:00MARIE CURIEPRBB-CRG SessionsGunter MeisterUniversity of Regensburg, DEto be determinedHost: Fátima Gebauer (CRG)

24/01/202012:00MARIE CURIEPRBB-CRG SessionsIgor UlitskyWeizmann Institute of Science, Rehovot, IL"Functions and modes of action of long noncoding RNAs in mammalian cells"Host: Jorge FerrerAbstract:We are interested in understanding the codes that drive the functions of long noncoding RNAs (lncRNAs) in mammalian cells. It is now well appreciated that the human genome encodes tens of thousands of distinct lncRNA transcripts, and an increasing number are implicated as regulators in critical pathways in health and disease. The mechanisms underlying their activity, to what extent these rely on specific sequences or structures, and how they are...

31/01/202012:00MARIE CURIEPRBB-CRG SessionsNicole SoranzoWellcome Sanger Institute, Hinxton, UK"to be determined"Host: Roderic Guigó

21/02/202012:00MARIE CURIEPRBB-CRG SessionsSimon AlbertiMax Planck Institute of Molecular Cell Biology and Genetics (MPI-CBd), Dresden, Germany"to be determined"Host: Sebastian Maurer

28/02/202012:00MARIE CURIEPRBB-CRG SessionsMichael KieblerBioMedizinisches Centrum, Lehrstuhl Zellbiologie (Anatomie III), LMU, Martinsried, Germany"to be determined"Host: Fátima Gebauer and Sebastian Maurer

06/03/202012:00MARIE CURIEPRBB-CRG SessionsHeiko LickertHelmholtz Zentrum München GmbH, Institute of Diabetes & Regeneration Research, Helmholtz Diabetes Centre, Germany"to be determined"Host: Jorge Ferrer

13/03/202012:00MARIE CURIEPRBB-CRG SessionsRab PrinjhaVP, Head of Epinova Epigenetics DPU, VP Head of Epigenetics DPU (Immuno- and Cancer-Epigenetics), GlaxoSmithKline, UK"to be determined"Host: Luciano Di Croce

20/03/202012:00MARIE CURIEPRBB-CRG SessionsErin ShcumanMax Planck Institute for Brain Research, Frankfurt, DE"to be determined"Host: Juan Valcárcel

27/03/202012:00MARIE CURIEPRBB-CRG SessionsJames HackettEMBL Rome, IT"to be determined"Host: CRG PhD Students

03/04/202012:00MARIE CURIEPRBB-CRG SessionsIñigo MartincorenaWellcome Sanger Institute, Hinxton, UK"to be determined"Host: CRG PhD Students

16/10/202012:00MARIE CURIEPRBB-CRG SessionsAnne Ferguson-SmithUniversity of Cambridge. Department of Genetics"to be determined"Host: Bernhard Payer